Perceptronix Appoints Ms. Rohini Hira, Vice President Sales and Marketing

Vancouver, Canada (ots/PRNewswire) - Perceptronix CEO Carl Roy
announced the appointment of Ms. Rohini Hira to the position of Vice
President Sales and Marketing effective December 15th, 2006. Ms.
Hira has the vision and experience to commercialize Perceptronix'
early cancer detection products and services in Canada, the US and
the EU.

Ms. Hira's career spans 20 years of success in global healthcare
marketing, including progressive sales and marketing management
positions with Merck, Genentech and Baxter. For the past five years,
Ms. Hira consulted for the biotech and medical device industries in
marketing and business development, and was the Director of
Marketing at VSM MedTech for the past two years. Prior to that, she
was instrumental in successfully establishing a leading medical
marketing, communications and technology company, Conceptis, where
she held the position of Vice President, Cardiovascular Business
Unit (and theheart.org(TM)). In hiring Ms. Hira, Perceptronix gains
her deep knowledge of the markets, her ability to manage products
from concept through to market entry, her successful record in
developing strategic relationships with key medical opinion leaders,
and her skill at negotiating world-wide distribution agreements.

"It is clear that Ms. Hira is passionate about bringing specialty
medical products, services and concepts to market," says Mr. Roy,
"and throughout her career she has worked collaboratively with
visionary, progressive teams." In her previous role as Vice
President at Conceptis, Ms . Hira negotiated, secured and managed
several wide-scale distribution, licensing, sales and co-promotion
agreements with billion dollar multinationals. One of her recent
corporate highlights was leveraging a significant global
distribution contract she negotiated, valued at approximately US$350
million, to secure an additional US$5 million in equity financing.

Ms. Hira's impressive and extensive accomplishments will be an
asset to Perceptronix as it commercializes its Health Canada and US
FDA approved, early cancer detection and diagnostic products and
services.

Perceptronix Medical Inc. is a Vancouver-based, privately-owned
cancer diagnostic company founded in June 1999 as a spin off of the
BC Cancer Agency. Perceptronix' mission is to commercialize effective
technologies to improve the early detection, localization, diagnosis
and follow-up of cancer, with an initial focus on lung cancer.
Perceptronix' products and services offer an improvement over
existing detection and localization technologies and provide
physicians with increased options for prolonging and improving the
quality of patients' lives.

ots Originaltext: Perceptronix Medical Inc.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: Media Contact: Amanda Smith, B.Sc, Smith
Biotech, Phone: +1-(778)-846-4116, Amanda@smithbiotech.com